People
“We are delighted to have these premier life science investors supporting our Series B financing,” said David J. Earp, Circle’s President and CEO.
Mily will be leading the company strategy and all business development activities. This includes overseeing strategic partnerships, mergers and acquisitions, etc.
The company did not know of her intention to leave the U.S. for China. They did not know she had been gone until the Chinese media reported the story. She was terminated by Biogen this week.
A summary of daily Biopharma industry news. Please check out stories that are trending on March 20, 2020.
Companies strengthen their leadership teams and board with this week’s Movers & Shakers.
Epidemiologists believe COVID-19 will likely affect millions of people in the U.S. If early prevention efforts are not made Swine Flu Pandemic of 2009.
A summary of daily Biopharma industry news. Please check out stories that are trending on March 19, 2020.
OncoOne currently has three drug candidates for four indications (colorectal, pancreatic, ovarian and lung cancers).
For nearly 30 years, Richard Miller has been at the forefront of developing treatments for lymphomas, most notably the multi-billion dollar breakthroughs Rituxan and Imbruvica. In recognition of his decades of work, Miller was awarded with the 2020 Drug Hunter Award.
Researchers found fear of testing new treatments and possible side effects were common denominators among patients.
PRESS RELEASES